Cytori Therapeutics ( CYTX) gained to 6.4% to $5.80 after the company announced that the Food and Drug Administration approved its fat tissue processing system for use with its Celase tissue processing reagent. The system is used for plastic and reconstructive, gastrointestinal, thoracic and other surgeries.

Among other health stock winners Thursday were Adams Respiratory Therapeutics ( ARXT), 1% higher to $45.47; Ligand Pharmaceuticals ( LGND),up 1.8% to $11.75; Kendle International ( KNDL), rising 2% to $36.55; and Tiens Biotech Group ( TBV), gaining 9.3% to 5.79.

Among the losers were Bristol-Myers Squibb ( BMY), down 2.1% to $26.42; Abbott Laboratories ( ABT), 1.6% lower to $52.70; Biogen Idec ( BIIB), falling 1.8% to $47.91; Genzyme ( GENZ), off 1.5% to $66.23; MedImmune ( MEDI), 1.5% lower to $34.19; Barr Pharmaceuticals ( BRL), down 1.1% to $54.88; and Vertex Pharmaceuticals ( VRTX), falling 3% to $35.18.

If you liked this article you might like

Nationwide Egg Recall Expanded

10 Toy Fads That Have Faded

Boomers Feel Recession Burden, Blame

KFC Franchisees Want 'Fried' to Be the Focus

Heavy Weights: More Expensive, Less Effective